BOSTON, Sept. 30, 2024 -- Aktis Oncology, a clinical-stage biotechnology company pioneering the discovery and development of novel targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today...
Scott Weiner is participating on a panel at the Greater Philadelphia Alliance for Capital and Technologies IMPACT 2010 Conference in Philadelphia, PA
News | 11. 09. 2010
